• 1. Toris CB, Gabelt BT, Kaufman PL. Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction. Surv Ophthalmol 2008;53:S107S120.

    • Search Google Scholar
    • Export Citation
  • 2. Toris CB, Zhan G, Zhao J, et al. Potential mechanism for the additivity of pilocarpine and latanoprost. Am J Ophthalmol 2001;131:722728.

    • Search Google Scholar
    • Export Citation
  • 3. Grierson I, Lee WR, Abraham S. Effects of pilocarpine on the morphology of the human outflow apparatus. Br J Ophthalmol 1978;62:302313.

    • Search Google Scholar
    • Export Citation
  • 4. Toris CB, Alm A, Camras CB. Latanoprost and cholinergic agonists in combination. Surv Ophthalmol 2002;47:S141S147.

  • 5. Kent AR, Vroman DT, Thomas TJ, et al. Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension. J Glaucoma 1999;8:257262.

    • Search Google Scholar
    • Export Citation
  • 6. Sarchahi AA, Abbasi N, Gholipour MA. Effects of an unfixed combination latanoprost and pilocarpine on the intraocular pressure and pupil size of normal dogs. Vet Ophthalmol 2012;15:6470.

    • Search Google Scholar
    • Export Citation
  • 7. Plummer CE, Regnier A, Gelatt KN. The canine glaucomas. In: Gelatt KN, ed. Veterinary ophthalmology. 5th ed. Oxford, England: Wiley-Blackwell, 2013;10501145.

    • Search Google Scholar
    • Export Citation
  • 8. Yoshitomi T, Ito Y. Effects of indomethacin and prostaglandins on the dog iris sphincter and dilator muscles. Invest Ophthalmol Vis Sci 1988;29:127132.

    • Search Google Scholar
    • Export Citation
  • 9. Carreras FJ, Porcel D, Gonzalez-Caballero F. Expanding forces in aqueous outflow pathways of a nonaccommodating mammal: an approach via comparative dynamic morphology. Comp Biochem Physiol A Physiol 1997;117:197209.

    • Search Google Scholar
    • Export Citation
  • 10. Gum GG, Metzger KJ, Gelatt KJ, et al. Tonographic effects of pilocarpine and pilocarpine-epinephrine in dogs. J Small Anim Pract 1993;34:112116.

    • Search Google Scholar
    • Export Citation
  • 11. Morrison JC, Van Buskirk EM. The canine eye: pectinate ligaments and aqueous outflow resistance. Invest Ophthalmol Vis Sci 1982;23:726732.

    • Search Google Scholar
    • Export Citation
  • 12. Samuelson D, Streit A. Microanatomy of the anterior uveoscleral outflow pathway in normal and primary open-angle glaucomatous dogs. Vet Ophthalmol 2012;15:4753.

    • Search Google Scholar
    • Export Citation
  • 13. Park S, Kang S, Lee E, et al. Ultrasound biomicroscopic study of the effects of topical latanoprost on the anterior segment and ciliary body thickness in dogs. Vet Ophthalmol 2016;19:498503.

    • Search Google Scholar
    • Export Citation
  • 14. Overby DR, Bertrand J, Schicht M, et al. The structure of the trabecular meshwork, its connections to the ciliary muscle, and the effect of pilocarpine on outflow facility in mice. Invest Ophthalmol Vis Sci 2014;55:37273736.

    • Search Google Scholar
    • Export Citation
  • 15. Miller PE, Bentley E. Clinical signs and diagnosis of the canine primary glaucomas. Vet Clin North Am Small Anim 2015;45:11831212.

  • 16. Alario AF, Strong TD, Pizzirani S. Medical treatment of primary canine glaucoma. Vet Clin North Am Small Anim 2015;45:12351259.

  • 17. Taniguchi T, Haque MSR, Sugiyama K, et al. Ocular hypotensive mechanism of topical isopropyl unoprostone, a novel prostaglandin metabolite-related drug, in rabbits. J Ocul Pharmacol Ther 1996;12:489498.

    • Search Google Scholar
    • Export Citation
  • 18. Richter M, Kraus AH, Woodward DF, et al. Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide. Invest Ophthalmol Vis Sci 2003;44:44194426.

    • Search Google Scholar
    • Export Citation
  • 19. Takagi Y, Nakajima T, Shimazaki A, et al. Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp Eye Res 2004;78:767776.

    • Search Google Scholar
    • Export Citation
  • 20. Miller PE. Study design and methodologies for evaluation of anti-glaucoma drugs. In: Gilger B, ed. Ocular pharmacology and toxicology. Methods in pharmacology and toxicology. Totowa, NJ: Humana Press, 2013;205242.

    • Search Google Scholar
    • Export Citation
  • 21. Gwin RM, Gelatt KN, Gum GG, et al. The effect of topical pilocarpine on intraocular pressure and pupil size in the normotensive and glaucomatous beagle. Invest Ophthalmol Vis Sci 1977;16:11431148.

    • Search Google Scholar
    • Export Citation
  • 22. Kahane N, Raskansky H, Bdolah-Abram T, et al. The effects of topical parasympatholytic drugs on pupil diameter and intraocular pressure in healthy dogs treated with 0.005% latanoprost. Vet Ophthalmol 2016;19:464472.

    • Search Google Scholar
    • Export Citation
  • 23. Smith LN, Miller PE, Felchle LM. Effects of topical administration of latanoprost, timolol, or a combination of latanoprost and timolol on intraocular pressure, pupil size, and heart rate in clinically normal dogs. Am J Vet Res 2010;71:10551061.

    • Search Google Scholar
    • Export Citation

Advertisement

Effects of prostaglandin-mediated and cholinergic-mediated miosis on morphology of the ciliary cleft region in dogs

Sangwan Park DVM1, Seonmi Kang DVM, PhD2, Jaegook Lim DVM3, Eunjin Park DVM4, Taekjin Nam DVM5, Seowoo Jeong DVM6, and Kangmoon Seo DVM, PhD7
View More View Less
  • 1 Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Republic of Korea.
  • | 2 Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Republic of Korea.
  • | 3 Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Republic of Korea.
  • | 4 Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Republic of Korea.
  • | 5 Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Republic of Korea.
  • | 6 Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Republic of Korea.
  • | 7 Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Republic of Korea.

Abstract

OBJECTIVE To compare morphology of the ciliary cleft (CC) region in dogs after topical administration of latanoprost, pilocarpine, or a combination of latanoprost and pilocarpine.

ANIMALS 6 Beagles.

PROCEDURES A prospective 4-phase crossover study with washout periods was performed. Latanoprost (phase L), pilocarpine (phase P), pilocarpine followed by latanoprost (phase PL), and latanoprost followed by pilocarpine (phase LP) were administered to the right eye. Artificial tears were administered to the left eye (control eye). For each phase, pupil diameter and intraocular pressure (IOP) were measured and ultrasonographic biomicroscopy was performed 2 hours after topical treatment. Angle opening distance (AOD), ciliary cleft width (CCW), ciliary cleft length (CCL), and ciliary cleft area (CCA) were evaluated.

RESULTS All treated eyes had marked miosis without significant differences in pupil diameter among phases. Significant IOP reductions were detected for all phases, except phase P. The AOD and CCA were significantly increased in all phases for treated eyes, compared with results for control eyes. The CCW was significantly increased in phases P, PL, and LP; CCL was significantly increased in phases PL and LP. Comparison of treated eyes among phases revealed that CCW differed significantly between phases L and P and between phases L and PL.

CONCLUSIONS AND CLINICAL RELEVANCE Prostaglandin-mediated and cholinergic-mediated miosis caused variations in CC configurations. When latanoprost and pilocarpine were used in combination, the first drug administered determined the cleft morphology, which was not fully reversed by the second drug. The CC morphology did not fully explain IOP reductions.

Contributor Notes

Address correspondence to Dr. Seo (kmseo@snu.ac.kr).